全文获取类型
收费全文 | 232篇 |
免费 | 10篇 |
国内免费 | 9篇 |
专业分类
基础医学 | 6篇 |
临床医学 | 3篇 |
内科学 | 9篇 |
皮肤病学 | 1篇 |
特种医学 | 3篇 |
外国民族医学 | 1篇 |
外科学 | 144篇 |
综合类 | 24篇 |
预防医学 | 1篇 |
药学 | 20篇 |
中国医学 | 4篇 |
肿瘤学 | 35篇 |
出版年
2023年 | 1篇 |
2022年 | 1篇 |
2021年 | 2篇 |
2020年 | 1篇 |
2019年 | 2篇 |
2018年 | 1篇 |
2017年 | 5篇 |
2016年 | 5篇 |
2015年 | 5篇 |
2014年 | 16篇 |
2013年 | 11篇 |
2012年 | 13篇 |
2011年 | 11篇 |
2010年 | 15篇 |
2009年 | 11篇 |
2008年 | 21篇 |
2007年 | 16篇 |
2006年 | 17篇 |
2005年 | 15篇 |
2004年 | 15篇 |
2003年 | 13篇 |
2002年 | 7篇 |
2001年 | 8篇 |
1999年 | 4篇 |
1998年 | 7篇 |
1997年 | 7篇 |
1996年 | 1篇 |
1995年 | 4篇 |
1994年 | 2篇 |
1993年 | 4篇 |
1992年 | 3篇 |
1989年 | 5篇 |
1988年 | 2篇 |
排序方式: 共有251条查询结果,搜索用时 15 毫秒
21.
G. J. van Steenbrugge M. Groen J. W. van Dogen J. Bolt H. van der Korput J. Trapman M. Hasenson J. Horoszewicz 《Urological research》1989,17(2):71-77
Summary The FGC (fast growing colony) line, a derivative of the LNCaP cell line shares all the main characteristics, including its androgen dependence, described for the original LNCaP cultures. A number of sublines originated from the FGC line which were characterized with respect to their response to steroiddepleted serum and to the synthetic androgen, R1881. After subcloning the FGC line a series of clones was isolated with distinct patterns of androgen-responsiveness. Among the sublines and clones studied, the FGC, FGC-JB and FGC clone-9 were androgen-dependent, whereas subline LNO, R and presumably also FGC clone-22 were androgen-independent. Distinct morphological differences were observed between the cells of the various sublines and between clone-9 and 22. The LNCaP cell line, its descending sublines and clonal derivatives provide a suitable in vitro model for studying different aspects of androgen-responsiveness of human prostate cancer.Part of this paper was presented at the 6th Congress of the European Society for Urological Oncology and Endocrinology, May 2–4, 1988, Innsbruck, Austria 相似文献
22.
23.
24.
25.
Shi XB Xue L Yang J Ma AH Zhao J Xu M Tepper CG Evans CP Kung HJ deVere White RW 《Proceedings of the National Academy of Sciences of the United States of America》2007,104(50):19983-19988
Although prostate cancer (CaP) is the most frequently diagnosed malignant tumor and the second leading cause of cancer deaths in American men, the mechanisms explaining the development and progression of CaP remain largely unknown. Recent studies have shown that some aberrantly expressed microRNAs (miRNAs) are involved in tumorigenesis. Although aberrant expression of certain miRNAs has been discovered in CaP, their function in this disease has not yet been defined. In this study, we found differential expression of miR-125b in androgen-dependent and independent CaP cells, as well as in benign and malignant prostate tissues. Furthermore, androgen signaling was able to up-regulate the expression of miR-125b. In addition, transfection of synthetic miR-125b stimulated androgen-independent growth of CaP cells and down-regulated the expression of Bak1. Our results suggest that miR-125b acts as an oncogene, contributing to the pathogenesis of CaP. 相似文献
26.
27.
Shaw G Price AM Ktori E Bisson I Purkis PE McFaul S Oliver RT Prowse DM 《European urology》2008,54(6):1333-1343
Objectives
Androgen-deprivation therapy effectively shrinks hormone-naïve prostate cancer, both in the prostate and at sites of distant metastasis. However prolonged androgen deprivation generally results in relapse and androgen-independent tumour growth, which is inevitably fatal. The molecular events that enable prostate cancer cells to proliferate in reduced androgen conditions are poorly understood. Here we investigate the role of Hedgehog signalling in androgen-independent prostate cancer (AIPC).Methods
Activity of the Hedgehog signalling pathway was analysed in cultured prostate cancer cells, and circulating prostate tumour cells were isolated from blood samples of patients with AIPC.Results
AIPC cells were derived through prolonged culture in reduced androgen conditions, modelling hormone therapy in patients, and expressed increased levels of Hedgehog signalling proteins. Exposure of cultured AIPC cells to cyclopamine, which inhibits Hedgehog signalling, resulted in inhibition of cancer cell growth. The expression of the Hedgehog receptor PTCH and the highly prostate cancer–specific gene DD3PCA3 was significantly higher in circulating prostate cancer cells isolated from patients with AIPC compared with samples prepared from normal individuals. There was an association between PTCH and DD3PCA3 expression and the length of androgen-ablation therapy.Conclusions
Our data are consistent with reports implicating overactivity of Hedgehog signalling in prostate cancer and suggest that Hedgehog signalling contributes to the androgen-independent growth of prostate cancer cells. As systemic anti-Hedgehog medicines are developed, the Hedgehog pathway will become a potential new therapeutic target in advanced prostate cancer. 相似文献28.
Wenqing Qi Carla Morales Laurence S. Cooke Benny Johnson Bradley Somer Daruka Mahadevan 《Oncotarget》2015,6(39):41976-41987
Gain-of-function of the androgen receptor (AR) and activation of PI3K/AKT/mTOR pathway have been demonstrated to correlate with progression to castration-resistant prostate cancer (CRPC). However, inhibition of AR or PI3K/mTOR alone results in a reciprocal feedback activation. Therefore, we hypothesized that dual inhibition of the AR and PI3K/mTOR pathway might lead to a synergistic inhibition of cell growth and overcome drug resistance in CRPC. Here, we reported that androgen-depletion increased AR protein level and Akt phosphorylation at Ser473 and Thr308 in LNCaP cells. Moreover, we developed resistance cell lines of LNCaP to Enzalutamide (or MDV3100), an AR inhibitor (named as LNCaP ‘MDV-R’) and PF-04691502, a PI3K/mTOR inhibitor (named as LNCaP ‘PF-R’). MTS analysis showed that LNCaP ‘PF-R’ was strongly resistant to Enzalutamide treatment, and on the other hand, LNCaP ‘MDV-R’ was 6-fold resistant to PF-04691502 treatment. Mechanistically, LNCaP ‘MDV-R’ cells had significantly reduced AR, loss of PSA and increase Akt activity in contrast with LNCaP ‘PF-R’ cells. Combined inhibition of PI3K/mTOR and AR pathways with a variety of small molecular inhibitors led to a synergistic suppression of cell proliferation and a profound increase of apoptosis and cell cycle arrest in both androgen-dependent LNCaP and independent CRPC 22Rv1 cell lines. In conclusion, this study provides preclinical proof-of-concept that the combination of a PI3K/mTOR inhibitor with an AR inhibitor results in a synergistic anti-tumor response in non-CRPC and CRPC models. 相似文献
29.
目的 探讨环巴胺(Cyclopamine)对人前列腺癌LNCaP细胞增殖和凋亡的影响.方法 不同浓度环巴胺(1、5、10、15μmol·L^-1)干预LNCaP细胞,分别在不同作用时间(24、48、72h)用MTT法检测环巴胺对LNCaP细胞增殖的抑制,Hoechst染色观察细胞凋亡形态的变化,流式细胞术检测细胞凋亡率的变化.结果 环巴胺5、10、15μmol·L^-1浓度组对LNCaP细胞增殖有显著抑制作用,与对照组相比差异有统计学意义(P<0.01).随着浓度的增大对细胞增殖的抑制作用显著增强.10μmol·L^-1组于48 h达到半数抑制量(IC50).环巴胺10μmol·L^-1组24、48、72h凋亡率分别为37.21%、57.38%、57.98%,15μmol·L^-1组凋亡率分别为21.16%、71.31%、72.90%,与对照组相比差异均有统计学意义(P<0.01).随着浓度的增大细胞凋亡率逐渐增大.细胞凋亡形态的改变随着环巴胺浓度增大和作用时间的延长而增强.结论 环巴胺能够明显抑制LNCaP细胞的增殖,诱导细胞凋亡. 相似文献
30.